134 results on '"C. Argyropoulos"'
Search Results
2. Enhanced Nonlinear Effects in Metamaterials and Plasmonics
- Author
-
C. Argyropoulos, P.-Y. Chen, and A. Alù
- Subjects
Metamaterials ,Plasmonics ,Nonlinear ,Physics ,QC1-999 ,Electricity and magnetism ,QC501-766 - Abstract
In this paper we provide an overview of the anomalous and enhanced nonlinear effects available when optical nonlinear materials are combined inside plasmonic waveguide structures. Broad, bistable and all-optical switching responses are exhibited at the cut-off frequency of these waveguides, characterized by reduced Q-factor resonances. These phenomena are due to the large field enhancement obtained inside specific plasmonic gratings, which ensures a significant boosting of the nonlinear operation. Several exciting applications are proposed, which may potentially lead to new optical components and add to the optical nanocircuit paradigm.
- Published
- 2012
- Full Text
- View/download PDF
3. A Methodology for the Hazard Assessment in large Hydrocarbon Fuel Tanks
- Author
-
Z. Nivolianitou, C. Argyropoulos, M. Christolis, and N. Markatos
- Subjects
Chemical engineering ,TP155-156 ,Computer engineering. Computer hardware ,TK7885-7895 - Abstract
This work presents a thorough hazards identification methodology for liquid hydrocarbon fuel storage tanks, by applying a checklist technique on the accident causes and the relevant protection measures, in the framework of implementing the SEVESO Directive series. A forum discussion with Greek industrial safety experts has also been organized by the authors in order to improve and correct any lack of the method. Results are presented and discussed, and it is concluded that the present hazard assessment method helps to identify the major contributors to risk, to improve safety measures and to assist the analysis in these aspects.
- Published
- 2012
- Full Text
- View/download PDF
4. Neutral vs. non-neutral genetic footprints of Plasmodium falciparum multiclonal infections.
- Author
-
Frédéric Labbé, Qixin He, Qi Zhan, Kathryn E. Tiedje, Dionne C. Argyropoulos, Mun Hua Tan, Anita Ghansah, Karen P. Day, and Mercedes Pascual
- Published
- 2023
- Full Text
- View/download PDF
5. Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
- Author
-
MacLachlan, K.H. Bagratuni, T. Kastritis, E. Ziccheddu, B. Lu, S. Yellapantula, V. Famulare, C. Argyropoulos, K. Derkach, A. Papaemmanuil, E. Dogan, A. Lesokhin, A. Usmani, S.Z. Landgren, C.O. Palomba, L.M. Maura, F. Dimopoulos, M.A. and MacLachlan, K.H. Bagratuni, T. Kastritis, E. Ziccheddu, B. Lu, S. Yellapantula, V. Famulare, C. Argyropoulos, K. Derkach, A. Papaemmanuil, E. Dogan, A. Lesokhin, A. Usmani, S.Z. Landgren, C.O. Palomba, L.M. Maura, F. Dimopoulos, M.A.
- Abstract
The genomic landscape of Waldenström macroglobulinemia (WM) is characterized by somatic mutations in MYD88, present from the precursor stages. Using the comprehensive resolution of whole genome sequencing (WGS) in 14 CD19-selected primary WM samples; comparing clonal and subclonal mutations revealed that germinal center (GC) mutational signatures SBS9 (poly-eta) and SBS84 (AID) have sustained activity, suggesting that the interaction betweenWMand the GC continues over time. Expanding our cohort size with 33 targeted sequencing samples, we interrogated the WM copy number aberration (CNA) landscape and chronology. Of interest, CNA prevalence progressively increased in symptomatic WM and relapsed disease when compared with stable precursor stages, with stable precursors lacking genomic complexity. Two MYD88 wild-type WGS contained a clonal gain affecting chromosome 12, which is typically an early event in chronic lymphocytic leukemia. Molecular time analysis demonstrated that both chromosomal 12 gain events occurred early in cancer development whereas other CNA changes tend to occur later in the disease course and are often subclonal. In summary, WGS analysis in WM allows the demonstration of sustained GC activity over time and allows the reconstruction of the temporal evolution of specific genomic features. In addition, our data suggest that, although MYD88-mutations are central to WM clone establishment and can be observed in precursor disease, CNA may contribute to later phases, and may be used as a biomarker for progression risk from precursor conditions to symptomatic disease. © 2023 by The American Society of Hematology.
- Published
- 2023
6. Measuring changes in Plasmodium falciparum var census population size and structure in response to sequential malaria control interventions
- Author
-
Kathryn E. Tiedje, Qi Zhan, Shazia Ruybal-Pésantez, Gerry Tonkin-Hill, Qixin He, Mun Hua Tan, Dionne C. Argyropoulos, Samantha L. Deed, Anita Ghansah, Oscar Bangre, Abraham R. Oduro, Kwadwo A. Koram, Mercedes Pascual, and Karen P. Day
- Subjects
Article - Abstract
The diversity ofPlasmodium falciparumwithin human hosts requires parasite population size be defined in terms of parasite variation rather than the number of infected hosts. To calculate census population size, we rely on a definition of parasite variation known as multiplicity of infection (MOIvar), defined by the hyper-diversity of thevarmultigene family. We present a Bayesian approach to estimate MOIvarbased on sequencing and counting the number of unique DBLα tags (or DBLα types) ofvargenes, taking into consideration measurement error, and derive from it census population size or the total number of distinct infections of relevance to transmission events. We track changes in parasite population size and structure, using MOIvar, from baseline and through sequential malaria interventions by indoor residual spraying (IRS) and seasonal malaria chemoprevention (SMC) in an area characterized by high-seasonal malaria transmission in northern Ghana.VarDBLα tag sequencing was completed on asymptomaticP. falciparumisolates at baseline (2012), during IRS (2014), post-IRS (2015) and during SMC (2017) from ∼2,000 individuals of all ages surveyed at each time point. Following IRS, which reduced transmission intensity by > 90% and decreased parasite prevalence by ∼40-50%, significant reductions invardiversity, MOIvar, and population size were observed across all ages. These changes, consistent with the loss of diverse parasite genomes, were short lived and 32-months after IRS was discontinued and SMC was introduced,vardiversity and population size rebounded in all age groups except for the younger children (1-5 years) targeted by SMC. By measuring population size in this way, we show that despite major perturbations, the parasite population remained very large and retained thevarpopulation genetic characteristics of a high-transmission system (highvardiversity; lowvarrepertoire similarity) demonstrating the resilience ofP. falciparumto short-term interventions in high-burden countries of sub-Saharan Africa.
- Published
- 2023
7. Comparison of molecular surveillance methods to assess changes in the population genetics of Plasmodium falciparum in high transmission
- Author
-
Anita Ghansah, Kathryn E. Tiedje, Dionne C. Argyropoulos, Christiana O. Onwona, Samantha L. Deed, Frédéric Labbé, Abraham R. Oduro, Kwadwo A. Koram, Mercedes Pascual, and Karen P. Day
- Abstract
A major motivation for developing molecular methods for malaria surveillance is to measure the impact of control interventions on the population genetics of Plasmodium falciparum as a potential marker of progress towards elimination. Here we assess three established methods (i) single nucleotide polymorphism (SNP) barcoding (panel of 24-biallelic loci), (ii) microsatellite genotyping (panel of 12-multiallelic loci), and (iii) varcoding (fingerprinting var gene diversity, akin to microhaplotyping) to identify changes in parasite population genetics in response to a short-term indoor residual spraying (IRS) intervention. Typical of high seasonal transmission in Africa, multiclonal infections were found in 82.3% (median 3; range 1-18) and 57.8% (median 2; range 1-12) of asymptomatic individuals pre- and post-IRS, respectively, in Bongo District, Ghana. Since directly phasing multilocus haplotypes for population genetic analysis is not possible for biallelic SNPs and microsatellites, we chose ~200 low-complexity infections biased to single and double clone infections for analysis. Each genotyping method presented a different pattern of change in diversity and population structure as a consequence of variability in usable data and the relative polymorphism of the molecular markers (i.e., SNPs < microsatellites < var). Varcoding and microsatellite genotyping showed the overall failure of the IRS intervention to significantly change the population structure from pre-IRS characteristics (i.e., many diverse genomes of low genetic similarity). The 24-SNP barcode provided limited information for analysis, largely due to the biallelic nature of SNPs leading to a high proportion of double-allele calls and a view of more isolate relatedness compared to microsatellites and varcoding. Relative performance, suitability, and cost-effectiveness of the methods relevant to sample size and local malaria elimination in high-transmission endemic areas are discussed.
- Published
- 2023
- Full Text
- View/download PDF
8. The impact of indoor residual spraying on Plasmodium falciparum microsatellite variation in an area of high seasonal malaria transmission in Ghana, West Africa
- Author
-
Mercedes Pascual, Samantha Deed, Kathryn E. Tiedje, Dionne C Argyropoulos, Victor Asoala, Shazia Ruybal-Pesántez, Maxwell A. Appawu, Karen P. Day, Kwadwo A. Koram, Abraham Oduro, and Samuel Dadzie
- Subjects
Insecticides ,Veterinary medicine ,genetic epidemiology ,microsatellite genotyping ,Mosquito Control ,Plasmodium falciparum ,Population ,Indoor residual spraying ,Outcrossing ,Biology ,Population and Conservation Genetics ,Ghana ,law.invention ,Effective population size ,law ,parasitic diseases ,Genetics ,medicine ,Humans ,Malaria, Falciparum ,education ,malaria elimination ,neutral genetic variation ,indoor residual spraying ,Ecology, Evolution, Behavior and Systematics ,education.field_of_study ,Genetic diversity ,Original Articles ,medicine.disease ,Cross-Sectional Studies ,Transmission (mechanics) ,Genetic structure ,Original Article ,Seasons ,Malaria ,Microsatellite Repeats - Abstract
Here, we report the first population genetic study to examine the impact of indoor residual spraying (IRS) on Plasmodium falciparum in humans. This study was conducted in an area of high seasonal malaria transmission in Bongo District, Ghana. IRS was implemented during the dry season (November–May) in three consecutive years between 2013 and 2015 to reduce transmission and attempt to bottleneck the parasite population in humans towards lower diversity with greater linkage disequilibrium. The study was done against a background of widespread use of long‐lasting insecticidal nets, typical for contemporary malaria control in West Africa. Microsatellite genotyping with 10 loci was used to construct 392 P. falciparum multilocus infection haplotypes collected from two age‐stratified cross‐sectional surveys at the end of the wet seasons pre‐ and post‐IRS. Three‐rounds of IRS, under operational conditions, led to a >90% reduction in transmission intensity and a 35.7% reduction in the P. falciparum prevalence (p
- Published
- 2021
- Full Text
- View/download PDF
9. Indoor residual spraying with a non-pyrethroid insecticide reduces the reservoir of
- Author
-
Kathryn E, Tiedje, Abraham R, Oduro, Oscar, Bangre, Lucas, Amenga-Etego, Samuel K, Dadzie, Maxwell A, Appawu, Kwadwo, Frempong, Victor, Asoala, Shazia, Ruybal-Pésantez, Charles A, Narh, Samantha L, Deed, Dionne C, Argyropoulos, Anita, Ghansah, Samuel A, Agyei, Sylvester, Segbaya, Kwame, Desewu, Ignatius, Williams, Julie A, Simpson, Keziah, Malm, Mercedes, Pascual, Kwadwo A, Koram, and Karen P, Day
- Subjects
parasitic diseases ,Article - Abstract
High-malaria burden countries in sub-Saharan Africa are shifting from malaria control towards elimination. Hence, there is need to gain a contemporary understanding of how indoor residual spraying (IRS) with non-pyrethroid insecticides when combined with long-lasting insecticidal nets (LLINs) impregnated with pyrethroid insecticides, contribute to the efforts of National Malaria Control Programmes to interrupt transmission and reduce the reservoir of Plasmodium falciparum infections across all ages. Using an interrupted time-series study design, four age-stratified malariometric surveys, each of ~2,000 participants, were undertaken pre- and post-IRS in Bongo District, Ghana. Following the application of three-rounds of IRS, P. falciparum transmission intensity declined, as measured by a >90% reduction in the monthly entomological inoculation rate. This decline was accompanied by reductions in parasitological parameters, with participants of all ages being significantly less likely to harbor P. falciparum infections at the end of the wet season post-IRS (aOR = 0.22 [95% CI: 0.19–0.26], p-value < 0.001). In addition, multiplicity of infection (MOI(var)) was measured using a parasite fingerprinting tool, designed to capture within-host genome diversity. At the end of the wet season post-IRS, the prevalence of multi-genome infections declined from 75.6% to 54.1%. This study demonstrates that in areas characterized by high seasonal malaria transmission, IRS in combination with LLINs can significantly reduce the reservoir of P. falciparum infection. Nonetheless despite this success, 41.6% of the population, especially older children and adolescents, still harboured multi-genome infections. Given the persistence of this diverse reservoir across all ages, these data highlight the importance of sustaining vector control in combination with targeted chemotherapy to move high-transmission settings towards pre-elimination. This study also points to the benefits of molecular surveillance to ensure that incremental achievements are not lost and that the goals advocated for in the WHO’s High Burden to High Impact strategy are realized.
- Published
- 2022
10. Executive Dysfunction, Social Cognition Impairment, and Gray Matter Pathology in Myotonic Dystrophy Type 2: A Pilot Study
- Author
-
Theodosiou, T. Christidi, F. Xirou, S. Karavasilis, E. Bede, P. Papadopoulos, C. Argyropoulos, G.D. Kourtesis, P. Pantolewn, V. Ferentinos, P. Kararizou, E. Velonakis, G. Zalonis, I. Papadimas, G. and Theodosiou, T. Christidi, F. Xirou, S. Karavasilis, E. Bede, P. Papadopoulos, C. Argyropoulos, G.D. Kourtesis, P. Pantolewn, V. Ferentinos, P. Kararizou, E. Velonakis, G. Zalonis, I. Papadimas, G.
- Abstract
Background: In contrast to myotonic dystrophy type 1, the cognitive and radiologic profile of myotonic dystrophy type 2 (DM2) is relatively poorly characterized. Objective: To conduct a pilot study to systematically evaluate cognitive and radiologic features in a cohort of Greek individuals with DM2. Method: Eleven genetically confirmed individuals with DM2 and 26 age-and education-matched healthy controls were administered the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS) to screen for impairment in multiple cognitive domains. MRI data were evaluated by morphometric analyses to identify disease-specific gray and white matter alterations. The following statistical thresholds were used for cognitive comparisons: P FDR< 0.05 and Bayes factor (BF10) >10. Results: The DM2 group exhibited cognitive impairment (ECAS Total score; P FDR= 0.001; BF10= 108.887), which was dominated by executive impairment (P FDR= 0.003; BF10= 25.330). A trend toward verbal fluency impairment was also identified. No significant impairments in memory, language, or visuospatial function were captured. The analysis of subscores revealed severe impairments in social cognition and alternation. Voxel-based morphometry identified widespread frontal, occipital, and subcortical gray matter atrophy, including the left superior medial frontal gyrus, right medial orbitofrontal gyrus, right operculum, right precuneus, bilateral fusiform gyri, and bilateral thalami. Conclusion: DM2 may be associated with multifocal cortical and thalamic atrophy, which is likely to underpin the range of cognitive manifestations mostly characterized by executive impairment and specifically by impaired social cognition. © 2022 Lippincott Williams and Wilkins. All rights reserved.
- Published
- 2022
11. Impact of COVID-19 Pandemic on Crude Mortality Rates Associated with Acute Kidney Injury Requiring Continuous Renal Replacement Therapy: A Single-Center Study
- Author
-
D. Perez Ingles, A. Illescas, N. Perryman Collins, N. Jordyn A, J.L. Marinaro, C. Argyropoulos, and J.P. Teixeira
- Published
- 2021
- Full Text
- View/download PDF
12. Combining OpenFlow and sFlow for an effective and scalable anomaly detection and mitigation mechanism on SDN environments
- Author
-
C. Argyropoulos, Vasilis Maglaris, Kostas Giotis, Dimitrios Kalogeras, and Georgios Androulidakis
- Subjects
OpenFlow ,sFlow ,Computer Networks and Communications ,business.industry ,Computer science ,Network packet ,020206 networking & telecommunications ,Denial-of-service attack ,02 engineering and technology ,Load balancing (computing) ,Firewall (construction) ,Software ,Scalability ,0202 electrical engineering, electronic engineering, information engineering ,020201 artificial intelligence & image processing ,Anomaly detection ,Routing control plane ,business ,Software-defined networking ,Computer network - Abstract
Software Defined Networks (SDNs) based on the OpenFlow (OF) protocol export control-plane programmability of switched substrates. As a result, rich functionality in traffic management, load balancing, routing, firewall configuration, etc. that may pertain to specific flows they control, may be easily developed. In this paper we extend these functionalities with an efficient and scalable mechanism for performing anomaly detection and mitigation in SDN architectures. Flow statistics may reveal anomalies triggered by large scale malicious events (typically massive Distributed Denial of Service attacks) and subsequently assist networked resource owners/operators to raise mitigation policies against these threats. First, we demonstrate that OF statistics collection and processing overloads the centralized control plane, introducing scalability issues. Second, we propose a modular architecture for the separation of the data collection process from the SDN control plane with the employment of sFlow monitoring data. We then report experimental results that compare its performance against native OF approaches that use standard flow table statistics. Both alternatives are evaluated using an entropy-based method on high volume real network traffic data collected from a university campus network. The packet traces were fed to hardware and software OF devices in order to assess flow-based data-gathering and related anomaly detection options. We subsequently present experimental results that demonstrate the effectiveness of the proposed sFlow-based mechanism compared to the native OF approach, in terms of overhead imposed on usage of system resources. Finally, we conclude by demonstrating that once a network anomaly is detected and identified, the OF protocol can effectively mitigate it via flow table modifications.
- Published
- 2014
- Full Text
- View/download PDF
13. Clinical Nephrology - Lab methods and other markers
- Author
-
W. Kleophas, B. Bieber, B. Robinson, J. Duttlinger, D. Fliser, G. Lonneman, L. Rump, R. Pisoni, F. Port, H. Reichel, R. Daniela, A. Ciocalteu, I. A. Checherita, I. Peride, D. M. Spataru, A. Niculae, K. Laetitia, K. Amna, D. Laurence, H.-A. Aoumeur, M. Flamant, J.-P. Haymann, E. Letavernier, E. Vidal-Petiot, J.-J. Boffa, F. Vrtovsnik, F. Bianco, G. Pessolano, M. Carraro, G. O. Panzetta, N. Ebert, J. Gaedeke, O. Jakob, M. Kuhlmann, P. Martus, M. Van der Giet, E. Scha ner, I. Khan, Y. Law, K. Turgutalp, O. Ozhan, E. Gok Oguz, A. Kiykim, C. Donadio, Z. N. Hatmi, M. Mahdavi-Mazdeh, E. Morales, V. Gutierrez-Millet, J. Rojas-Rivera, A. Huerta, E. Gutierrez, E. Gutierrez-Solis, N. Polanco, J. Caro, E. Gonza z, M. Praga, M. Marco Mayayo, J. Valdivielso, M. Marti z, E. Fernaez Giraez, G. Obrador, N. Olvera, D. Ortiz de la Pe, V. Gutie ez, A. Villa, B. Redal-Baigorri, K. Sombolos, D. Tsakiris, J. Boletis, D. Vlahakos, K. Siamopoulos, V. Vargiemezis, P. Nikolaidis, C. Iatrou, E. Dafnis, C. Argyropoulos, K. Xynos, D. Schock-Kusch, Y. Shulhevich, S. Geraci, J. Hesser, D. Stsepankou, S. Neudecker, S. Koenig, F. Hoecklin, J. Pill, N. Gretz, F. Schweda, A. Schreiber, K. Kudo, T. Konta, S. O. Choi, J. S. Kim, M. K. Kim, J. W. Yang, B. G. Han, P. Delanaye, E. Cavalier, I. Masson, M. Mehdi, M. Nicolas, B. Lambermont, B. Dubois, P. Damas, J.-M. Krzesinski, J. Morel, A. Lautrette, M. Christophe, A. Gagneux-Brunon, F. Anne, L. Fre (C)ric, S. Bevc, R. Ekart, R. Hojs, M. Gorenjak, L. Puklavec, N. Hashimoto, A. Suzuki, K. Mitsumoto, M. Shimizu, K. Niihata, A. Kawabata, Y. Sakaguchi, T. Hayashi, T. Shoji, N. Okada, Y. Tsubakihara, T. Hamano, C. Nakano, N. Fujii, Y. Obi, S. Mikami, K. Inoue, I. Matsui, Y. Isaka, H. Rakugi, V. Edvardsson, B. Siguron, M. Thorsteinsdottir, R. Palsson, J. Matsumoto, N. Miyazaki, I. Murata, G. Yoshida, K. Morishita, H. Ushikoshi, K. Nishigaki, S. Ogura, S. Minatoguchi, U. Werneke, M. Ott, E. Salander-Renberg, D. Taylor, B. Stegmayr, S. Surel, M. Wenzlova, G. Silva Junior, A. P. Vieira, A. Couto Bem, M. Alves, A. Torres, G. Meneses, A. Martins, A. Liborio, E. Daher, G. Gluhovschi, M. Modilca, L. Daminescu, C. Gluhovschi, S. Velciov, L. Petrica, F. Gadalean, C. Balgradean, H. H. Schmeiser, M. Kolesnyk, N. Stepanova, L. Surzhko, N. Stashevska, V. Filiopoulos, D. Hadjiyannakos, D. Arvanitis, K. Panagiotopoulos, D. Vlassopoulos, N. Kaesler, T. Schettgen, E. Magdeleyns, V. Brandenburg, C. Vermeer, J. Floege, T. Kr, O. Randone, M. Ferraresi, E. Aroasio, A. Depascale, S. Scognamiglio, V. Consiglio, G. B. Piccoli, L. V. Jensen, S. Lizakowski, P. Rutkowski, L. Tylicki, M. Renke, B. Sulikowska, R. Donderski, R. Bednarski, Z. Heleniak, M. Przybylska, J. Manitius, B. Rutkowski, L. Bobrova, N. Kozlovskaya, K. Kanayama, M. Hasegawa, F. Kitagawa, J. Ishii, Y. Yuzawa, K. Tanaka, K. Sakai, S. Hara, Y. Suzuki, Y. Tanaka, A. Aikawa, F. Hinoshita, N. Hamano, E. Sasaki, A. Kato, T. Katsuki, A. Katsuma, E. Imai, M. Shibata, M. Tada, T. Shimbo, Y. Kikuchi, S. Oka, T. Muramatsu, N. Yanagisawa, K. Fukutake, Y. Yamamoto, A. Ajisawa, K. Tsuchiya, K. Nitta, M. Ando, X. Liang, P. Wang, Z. Liu, Z. Zhao, V. Luyckx, S. Bowker, A. Miekle, E. Toth, R. Heguilen, A. Malvar, R. Hermes, L. Cohen, G. Muguerza, B. Lococo, A. Bernasconi, O. Loboda, I. Dudar, V. Krot, V. Alekseeva, M. Ichinose, N. Sasagawa, K. Toyama, A. Saito, Y. Kayamori, D. Kang, H. W. Kim, K. Yoshioka, M. Hara, K. Ohashi, A. Maksudova, T. Khalfina, A. Cuoghi, E. Bellei, M. Caiazzo, S. Bergamini, G. Palladino, E. Monari, A. Tomasi, E. Loiacono, R. Camilla, V. Dapr, L. Morando, R. Gallo, L. Peruzzi, M. Conrieri, M. Bianciotto, F. M. Bosetti, R. Coppo, L. DI Lullo, F. Floccari, R. Rivera, A. Granata, R. Faiola, C. Feliziani, A. Villani, M. Malaguti, A. Santoboni, K. Kyriaki, J. Droulias, M. Bogdanova, V. V. Rameev, A. H. Simonyan, L. V. Kozlovskaya, M. R. Altiparmak, S. Trabulus, N. Akalin, A. S. Yalin, A. Esenkaya, S. F. Yalin, K. Serdengeae(C), D. Arita, T. Cunha, J. Perez, M. Sakata, L. Arita, M. Nogueira, Z. Jara, N. Souza, D. Casarini, M. Metzger, M. Vallet, A. Karras, M. Froissart, B. Stengel, P. Houillier, K. Paul, D. Kretzschmar, A. Yilmaz, B. Ba hlein, S. Titze, H.-R. Figulla, G. Wolf, M. Busch, Y. Korotchaeva, N. Gordovskaya, L. Kozlovskaya, K. P. Ng, P. Sharma, S. Stringer, M. Jesky, M. Dutton, C. Ferro, P. Cockwell, S. J. Moon, S. C. Lee, S. Y. Yoon, J. E. Lee, S. J. Han, B. Anna, T. Kirsch, L. Svjetlana, P. Joon-Keun, B. Jan, K. Johanna, H. Haller, M. Haubitz, A. Smirnov, I. Kayukov, N. Rafrafi, O. Degtereva, V. Dobronravov, M. Koch, H. Stefan, G. Dika, M.-H. Antoine, C. Husson, J. Kos, M. Milic, M. Fucek, D. Cvoriocec, M.-F. Bourgeade, J. L. Nortier, B. Jelakovic, E. H. Nawal, M. Naoufal, M. Nabila, E. M. Fadwa, E. K. Salma, B. Nisrine, Z. Mohamed, M. Guislaine, B. Mohamed Gharbi, R. Benyounes, G. G. Sotila, R. Sorin, D. Irina Magdalena, C. Roxana, R. Claudia, F. Correa Barcellos, P. H. Hallal, M. Bohlke, F. Boscolo Del Vechio, A. Reges, I. Santos, G. Mielke, M. Fortes, B. Antunez, M. Laganovic, I. Vukovic Lela, S. Karanovic, J. Seric, V. Premuic, M. Fitrek, L. Fodor, T. Meljkovic Vrkic, V. Bansal, D. Hoppensteadt, and J. Fareed
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Medicine ,Medical physics ,Clinical nephrology ,business - Published
- 2012
- Full Text
- View/download PDF
14. Threat and anxiety affect visual contrast perception
- Author
-
IGb Pallikaris, Pa Bitsios, S b Plainis, S c Argyropoulos, and Ga b Laretzaki
- Subjects
Adult ,Male ,medicine.medical_specialty ,genetic structures ,Poison control ,Anxiety ,Neuropsychological Tests ,Audiology ,Stimulus (physiology) ,Severity of Illness Index ,Developmental psychology ,Contrast Sensitivity ,Young Adult ,Form perception ,Reaction Time ,medicine ,Humans ,Pharmacology (medical) ,Pharmacology ,Visual search ,Electroshock ,Fear ,Form Perception ,Psychiatry and Mental health ,Visual cortex ,medicine.anatomical_structure ,P100 Latency ,Evoked Potentials, Visual ,Female ,medicine.symptom ,Psychology ,State-Trait Anxiety Inventory - Abstract
Threat cues activate the visual cortex and are detected faster than neutral cues as evidenced by functional brain imaging during viewing of visual threat and neutral stimuli. The functional visual processes underlying these phenomena have not been determined. Pattern visual evoked potentials were elicited in a baseline and a verbal threat condition with two stimulus contrasts in subjects with high and low trait anxiety. Threat reduced the latency of the early P100 wave in the low but not the high anxious group. The reduction was greater with increasing stimulus contrasts. The dependence of the P100 latency on trait anxiety is reminiscent of the Yerkes-Dodson inverted U-shape curve, which relates anxiety to behavioural responses. These results show that threat affects perceptual processes and suggest that data based on the effects of threat in visual search studies should be reappraised to include acceleration of contrast perception.
- Published
- 2008
- Full Text
- View/download PDF
15. Control-plane slicing methods in multi-tenant software defined networks
- Author
-
C. Argyropoulos, Dimitrios Kalogeras, Spyridon Mastorakis, Vasilis Maglaris, Kostas Giotis, and Georgios Androulidakis
- Subjects
OpenFlow ,Multitenancy ,Computer science ,business.industry ,Distributed computing ,Network virtualization ,Virtualization ,computer.software_genre ,Network topology ,Slicing ,Isolation (database systems) ,business ,Software-defined networking ,computer ,Computer network - Abstract
In this paper, we focused on two prevailing architectural approaches for control-plane virtualization in multi-tenant OpenFlow-ready SDN domains: The first permits the delegation of a specific, non-overlapping part of the overall flowspace to each tenant OpenFlow controller, exposing him/her the entire substrate topology; the second conceals the substrate topology to tenants by abstracting resources and exposing user-controlled (tenant) Virtual Networks (VNs). For both cases, we propose and analyze three control-plane slicing methods (domain, switch and port-wide), enforced by the management plane, that safeguard control-plane isolation among tenant VNs. Their effectiveness is assessed in terms of control-plane resources (number of flowspace policy rule entries, table lookup times and memory consumption) via measurements on a prototype implementation. To that end, we introduced and prototyped the Flowspace Slicing Policy (FSP) rule engine, an automated mechanism translating substrate management-plane policies into VN mapping control-plane rules. Our experiments, involving thousands of tenants VN requests over a variety of WAN-scale network topologies (e.g. Internet2/OSE3 and GEANT), demonstrate that the port-wide slicing method is the most efficient in terms of tenant request acceptance ratio, within acceptable control-plane delays and memory consumption.
- Published
- 2015
- Full Text
- View/download PDF
16. Renal safety profile of Lopinavir/ritonavir (LPV/r)-based regimens in the PROGRESS study
- Author
-
B Renjifo, Dilek Arikan, Roger Trinh, A Nilius, C Argyropoulos, and R Stubbs
- Subjects
Oncology ,Safety profile ,medicine.medical_specialty ,Infectious Diseases ,business.industry ,Internal medicine ,Public Health, Environmental and Occupational Health ,medicine ,Lopinavir/ritonavir ,business ,medicine.drug - Published
- 2013
- Full Text
- View/download PDF
17. Shockwave lithotripsy in unrecognized pregnancy: Interruption or continuation?
- Author
-
Deliveliotis, C Argyropoulos, B Chrisofos, M Dimopoulos, CA
- Abstract
A 32-year-old woman underwent SWL of a 4 X 6-mm calculus in the distal third of the right ureter, receiving 2100 shocks at a maximum intensity of 18 kV. Approximately I month later, it was discovered that she had been 10 weeks pregnant at the time of SWL. She chose to continue the pregnancy and delivered a normal infant at term. We do not advocate SWL in pregnancy, but further research is mandatory to determine if this procedure can ever be performed safely during pregnancy.
- Published
- 2001
18. Protein-energy wasting, inflammation and oxidative stress in CKD 5D
- Author
-
L. Rosales, O. Vega, L. Usvyat, S. Thijssen, N. Levin, P. Kotanko, T. Miyamoto, A. Witasp, A. Rashid Qureshi, O. Heimburger, P. Barany, L. Nordfors, B. Lindholm, P. Stenvinkel, J. Jesus Carrero, M. Kalousova, H. Benakova, A. A. Kubena, S. Dusilova-Sulkova, V. Tesar, T. Zima, Y. J. Lee, M. S. Kim, B. G. Song, S. Cho, S. R. Kim, M. Stockler-Pinto, J. Lobo, C. Moraes, A. Barros, N. Farage, G. Boaventura, D. Mafra, O. Malm, S. Matsuda, N. Akaike, K. Kajiwara, D. Tovbin, S. Kesari, D. Sola-Del Valle, J. Barasch, A. Douvdevani, M. Zlotnik, A. Abd Elkadir, S. Storch, M. Sarikaya, F. Sari, J. Gunes, M. Eren, R. Cetinkaya, J.-C. Hwang, T.-L. Ma, C.-T. Wang, H. Ogawa, T. Nagaya, Y. Ota, M. Sarai, O. Oda, B. Biavo, C. Uezima, M. E. Costa, C. Barros, J. P. Martins, E. Ribeiro Jr, C. Tzanno-Martins, H. Honda, N. Kimata, K. Wakai, T. Akizawa, J. Droulias, V. Filliponi, C. Argyropoulos, R. Fischer, C. Papakonstantinou, C. Papadopoulos, A. Kouvelis, G. Zervas, E. Dampolia, N. Zerefos, D. Valis, C. Sarcina, I. Baragetti, P. Uboldi, L. Buzzi, K. Garlaschelli, F. Ferrario, V. Terraneo, G. D. Norata, A. L. Catapano, C. Pozzi, G. Conti, D. Santoro, D. Caccamo, S. Condello, D. Pazzano, V. Savica, R. Jentile, C. Fede, G. Bellinghieri, R. Zortcheva, V. Ikonomov, B. Galunska, D. Paskalev, D. Dobreva, D. Ivanova, M. Tsunoda, R. Ikee, N. Sasaki, N. Sato, N. Hashimoto, L. Korol, I. Dudar, L. Migal, Y. Gonchar, I. Seleznova, V. Ischenko, M. Erkmen Uyar, E. Tutal, Z. Bal, N. Ahmed, S. Sezer, D. Fedak, M. Kuzniewski, D. Pawlica, B. Kusnierz-Cabala, B. Solnica, M. Drozdz, K. Janda, W. Sulowicz, J. Kopec, M. Banach, and V. Leal
- Subjects
Transplantation ,medicine.medical_specialty ,Endocrinology ,Nephrology ,business.industry ,Internal medicine ,medicine ,Inflammation ,Protein energy wasting ,medicine.symptom ,medicine.disease_cause ,business ,Oxidative stress - Published
- 2011
- Full Text
- View/download PDF
19. Physical properties of a periodontal dressing material
- Author
-
J A, von Fraunhofer and D C, Argyropoulos
- Subjects
Analysis of Variance ,Resins, Synthetic ,Acid Etching, Dental ,Tensile Strength ,Materials Testing ,Dental Bonding ,Humans ,Water ,Periodontal Dressings ,Dental Enamel ,Resin Cements - Abstract
Further characterization has been undertaken of a visible light cured periodontal dressing material (Barricaid), which has been shown to exhibit superior physical properties to those of the standard (chemically curing) dressing materials. In particular, water sorption and solubility were studied, with a greater solubility found at 37 degrees than at 23 degrees with little further increase at 50 degrees C. Water sorption increased from 23 degrees C to 37 degrees C but decreased at 50 degrees C. Cure depth, determined by a penetrometer method, showed a constant resistance of 5.8 kg to probe penetration to a material thickness of 11 mm but resistance to penetrometer penetration, i.e. the level of cure, decreased sharply at greater thickness. The tensile strength of the material was unchanged when immersed up to 7 days in water at 37 degrees C, indicating a highly coherent material unaffected by water over a period corresponding to average clinical use. Previous studies showed that interlocking into the embrasures was required for adequate adhesion of Barricaid. To overcome this problem, teeth were etched and a bonding agent applied to the etched enamel surface. This chemo-mechanical lock gave an immediate adhesion value of 43.94 MPa, which decreased to 37.17 MPa at 7 days. The immediate adhesion value without etching and bonding was 34.23 MPa which decreased to 19.32 MPa at 7 days. Soaking decreased adhesion to enamel, but the effect was markedly less when the enamel was pretreated by etching and priming.
- Published
- 1992
20. Diabetes mellitus - clinical studies - 2
- Author
-
A. Sattar, István Wittmann, Domenico Corradi, M. Haapio, Bernhard M.W. Schmidt, Susumu Ogawa, Ruth Mitchell, Carlos Alberto Mayora Aita, Colin J. Meyer, Peter-Rene Mertens, Esztella Mikolás, P. Miarka, Tatjana Cvetkovic, Ling Li, Georgios Hadjigeorgiou, J.A. Kellum, JoséMauro Vieira, Pál Brasnyó, Vuddhidej Ophascharoensuk, Hiroshi Sato, Eszter Fehér, Mártóon Mohás, Julia B. Lewis, Yusuke Osaki, Ulrike Raff, Tuneo Ishizuka, Mirela Liana Gliga, Sadayoshi Ito, Maximilian von Eynatten, Augusto Vaglio, Spyridon Arampatzis, Ramesh Chandra Vyasam, F. Nurhan Ozdemir, Jutalai Tanterdtham, M. Walus-Miarka, Marcus Baumann, Laura Pavone, Ausilia Maione, Carlos Kornhauser, Weiqian Sun, Renate Koppensteiner, Myrto Giannopoulou, Grigore Aloiziu Dogaru, Nestor Schor, August Heidland, Srilatha Vadlamudi, C. Argyropoulos, Peter Boor, Somkiat Vasuvattakul, L. Weissfeld, Alessandra Palmisano, Gloria Barbosa-Sabaner, M. Stompor, Jae Sung Lee, Demet Yavuz, Vladimir Arandjelovic, Ioanna Chronopoulou, Paisal Parichatikanond, Maria Goretti Polito, Takashi Nakamichi, Masanori Ito, Denise H.M.P. Diniz, Katarína Šebeková, T. Grodzicki, Bi-Cheng Liu, Toshio Mochizuki, Federico Alberici, Roberto Zatz, Jamille Godoy Mendes, Pingyan Shen, M. de Cal, Qi Long, Tadayuki Okumoto, M. Unruh, Nan Chen, Kraiwiporn Kiattisunthorn, Predrag Vlahovic, Gerit-Holger Schernthaner, Carlo Salvarani, Ilma Modanez, Per M. Humpert, Stacey Ruiz, Peggy Gao, Boonyarit Cheunsuchon, M. Batur Canoz, Lei Yan, Guntram Schernthaner, Dietmar Zdunek, Maria Dardioti, Claudio Ronco, Simeone Andrulli, Silvia M. Titan, Hans-Henrik Parving, Mohammed Bashir, Roland E. Schmieder, Florian Hoellerl, Hideyuki Inoue, Kristína Klenovicsová, Daniel Cruz, W. Sulowicz, Norman K. Hollenberg, Antonio Nicolucci, Ioannis Stefanidis, Donal O'Shea, Paulo C. Fortes, Vladislav Stefanovic, Seiji Hashimoto, Edmund J. Lewis, Ines Casazza, F. Nalesso, Wattana B. Watanapa, Rosario Foti, Sasa Milenkovic, Sherwyn Schwartz, Gianna Mastroianni-Kirsztajn, Takayuki Yamada, Judit Cseh, Athakorn Kirakul, M. Krzanowski, Johannes Mann, Efthymios Dardiotis, Jeffrey G. Supko, T J Cawood, Angelika Bierhaus, Chiara Grasselli, Cornelia Zumpe, E. Chowaniec, Wen Zhang, Hyeong Cheon Park, Takuma Hosoya, Mihai Gliga, Frederik Persson, Pablo Pergola, Erika Oliveira da Silva, Jicheng Lv, Chien-Te Lee, Tasuku Nagasawa, Noemi Gutierrez-Romero, Alberto Pesci, Karsten Kreuer, Sung Jin Moon, Douglas Denham, Roberto Pecoits-Filho, Hong Zhang, Kriengsak Vareesangthip, B. Ciepiela, Miguel C. Riella, A.A. House, Ke-Dan Cai, Terry Ting-Yu Chiou, Silvia Regina Moreira, Ravi Raju Tatapudi, Craig A. Hurwitz, Davide Martorana, Peter P. Nawroth, Giovanni F.M. Strippoli, István András Szijártó, Jung Eun Lee, Inés Birlouez-Aragon, Takao Koike, Hong Ren, kos Mérei, Ampica Mangklabruk, Gabriella Moroni, Hai-yan Wang, Veronika Somoza, Thomas K. Schwarz, Johanna Brix, Branka Mitic, Zi-Lin Sun, Saori Nishio, Sufang Shi, Sung Kyu Ha, Xiaoxia Pan, Ravi Shankar Subramaniam, Georg Hess, P. Lentini, Prasad Gullipalli, Siren Sezer, Sankar D. Navaneethan, Soung Rok Sim, Marcel Roos, Rui Toledo Barros, Uwe Heemann, Jennifer Brady, Kazuhiro Nako, Markus P. Schneider, Barbara Murray, Tibor Vas, M. Dubiel, Giselle Saavedra, Carlo Buzio, Vidojko Djordjevic, Rue-Tsuan Liu, Daisuke Ito, Vassilios Liakopoulos, T. Stompor, Suchai Sritippayawan, Carmen Caldararu, and Takefumi Mori
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Internal medicine ,Diabetes mellitus ,medicine ,business ,medicine.disease - Published
- 2009
- Full Text
- View/download PDF
21. Epidemiology and outcome - 2
- Author
-
Peter Bárány, F. Lladós, Gisela Sturm, Andrea Remuzzi, Brenda W. Gillespie, John L. Griffith, Abdul Rashid Qureshi, Heinz Jürgen Roth, Peter Stenvinkel, H.C. Rayner, Glenn M. Chertow, Anna Bednarek, Tiziana Di Paolantonio, Patricia de Sequera, Simona Hogas, Ray Krediet, J.A. Kellum, Piero Ruggenenti, F. Nurhan Ozdemir, Maria Concetta Vaccaro, Hiroko Inagaki, Ausilia Maione, Hal Morgenstern, Paolo Parini, Asta Auerbach, Jana Smrzova, Muhammad Shahed Ahmed, Daniel Rajdl, Mônica Viegas Andrade, Emanuel Zitt, Karen Amar, Véronique Joyeux, L. Weissfeld, Cacia Mendes Matos, David M. Kent, Marta Lugo, Marit Jordhoy, A. Martín-Malo, Odilon Vanni de Queiroz, Márcia Tereza Silva Martins, Maurice Alan Brookhart, Navdeep Tangri, A. Casula, Maria Luisa Lozano, Francesco Locatelli, Ursula Caceres, Jorgen Hegbrant, Shouichi Fujimoto, Antonio Nicolucci, Dulce Nicolas, K. Pitcher, Matthew Howse, Isabel Cristina Gomes, X. Cuevas, Nathan W. Levin, J. Fort, Antonio Piccoli, Shigehiro Uezono, Mark R. Marshall, Gordon Prescott, F.K. Port, Keith Simpson, Tomislav Bozek, Taina Lara Campos Cordeiro Valadares, Günter Edenharter, Toril Dammen, Kellie Hunter Campbell, Fabio Pellegrini, J. Lozano, Catherine Vérove, Jennifer Ennis, Claudia Barth, Mostapha Elallam, Michal Vostry, M. Unruh, Jaroslav Racek, Nistor Ionut, Nicole Stankus, Jaromír Eiselt, Milan Petrovic, Bolesław Rutkowski, lle Pechter, Cécile Couchoud, D.J. de Jager, Paul M. Just, R. Pérez-García, Yoav Ben-Shlomo, Lucia Guidotti, Karl Lhotta, Nicola Palmieri, Graciela Voronovitsky, William Dale, Merike Luman, Christoph Wanner, B.M. Robinson, Daniel Resende Faleiros, Paul Stroumza, Robert Mactier, C. Argyropoulos, Ognjenka Djurdjev, Kevan R. Polkinghorne, Juan Nin Ferrari, Bruce G. Robinson, Gelfman Ruben, Naoko Ikeda, Elviira Seppet, David Ansell, Marion Verduijn, Kirsten Haas, Bengt Lindholm, Jan Dulawa, Marcello Tonelli, Olof Heimbürger, E.W. Boeschoten, Juan Jesus Carrero, Adeera Levin, Dina Montasser, Gildete Barreto Lopes, Omar Maoujoud, Agostino Naso, Luminita Voroneanu, Paul Gusbeth-Tatomir, Brian D. Bradbury, Seema Sondhi, Margit Muliin, Valjbona Prelevic, Pierre Donnadieu, Giovanni F.M. Strippoli, Diana C. Grootendorst, Ingrid Os, Bogdan Ene-Iordache, Lada Malanova, Sergio Carminati, Keiko Kodama, J. Gilg, Mario Plebani, Inga Mandac, Sebnem Karakan, Pajica Pavkovic, Seiichiro Hara, Pedro Trinidad, Olga Sergeyeva, Oscar Bracchi, Yassir Zajari, Mohammed Hassani, Jonathan Bazeley, F. Tentori, Hans-Jürgen Schober-Halstenberg, Inger Hilde Nordhus, Mathilde Lassalle, Akira Saito, Marietta Torok, Ingrid Prkacin, Külli Kõlvald, Valjbona Preljevic, Yun Li, Martin Wagner, Ulrich Neyer, Elisabeth Reiss, Alberto Menegotto, Hannelore Sprenger-Mähr, Siiri Mesikepp, Vidojko Djordjevic, Marianna Zsom, Luis Espejo, Siren Sezer, Friedrich K. Port, Naser Tayebi, Mohammed Alayoud, Antonio Alberto Lopes, Simon Sawhney, Ruben Lopez, Augusto Afonso Guerra Junior, R.L. Pisoni, Stephen McDonald, Abdelali Bahadi, Shunichi Fukuhara, Gero von Gersdorff, Bruno Saligari, Zouhir Oualim, Alexandra Kitazawa, Marinella Ruospo, Mohammed Asseraji, Jorge Velez, Mathias Schaller, Lin Tong, Cesar Cruzalegui, Stevan Glogovac, Monserrat Morales, Peter C. Thomson, Alison M. MacLeod, M. Heaton, Nicola D'Ambrosio, Felipe Vazquez, A. Hodsman, Michał Chmielewski, F.W. Dekker, David R. Walker, Ronald L. Pisoni, H. Morgenstern, Martin Gomez, Charles R.V. Tomson, Letizia Gargano, Jamie P. Traynor, Anca Seica, Len A. Usvyat, Michela Sciancalepore, Jun Liu, Rolfdieter Krause, Francisco de Assis Acurcio, M.J. Blayney, M.E. Roumelioti, J. Davies, Bénédicte Stengel, Emmanuel Villar, Alan M. Brookhart, Carolyn Hunter, Catherine Wall, Tone Hortemo sthus, Adrian Covic, Michel Labeeuw, Peter Kotanko, Marco Murgo, P.G. Kerr, Stefan Arver, Moncef Kadiri, Giuseppe Remuzzi, Bertha Martinez, Ulrich Frei, Maria Lucia Sambati, R.T. Krediet, Paul Roderick, Y.Z. Shah, Florian Kronenberg, Taoufiq Aatif, Madis Ilmoja, Liliana Pinelli, Luc Frimat, Giovanni Cancarini, Ferruccio Conte, Wolfgang C. Winkelmayer, F. García, Rinaldo Di Toro Mammarella, Ronan Cunningham, Ermelinda Santiago, Giuseppe Accogli, Luciana Gravellone, Carmen Bonifati, Mihai Onofriescu, Eli Iola Gurgel Andrade, Friederike Lins, Els Boeschoten, A. Cheung, Michel Jadoul, Elaheh Dashti, Dolapo Ayansina, Monica Maria Mion, Edoardo Celia, Julio Gomez, Aleksander Lõhmus, Inger K. Laegreid, Eberechi Sandra Agwa, Ladislav Trefil, Friedo W. Dekker, Anna Casula, Austin G. Stack, Norberto Perico, Brian Bieber, George Mellotte, Mai Rosenberg, Hoang Nguyen, Conrad A. Baldamus, Daniele Araújo Campos Szuster, Abbas Ali Zeraati, Marta Codognotto, Tomáš Urbánek, Otto Freistätter, Alessandra Maciel Almeida, Massih Naghibi, and Stephan Thijssen
- Subjects
03 medical and health sciences ,Transplantation ,medicine.medical_specialty ,0302 clinical medicine ,Nephrology ,business.industry ,Epidemiology ,030232 urology & nephrology ,medicine ,Intensive care medicine ,business ,Outcome (game theory) - Published
- 2009
- Full Text
- View/download PDF
22. Effect of abnormal atmospheric pressure conditions upon mouse liver δ-aminolevulinic acid synthetase activity
- Author
-
Yalouris, A.G. Lyberatos, C. Argyropoulos, A. Papasteriadis, E. Raptis, S.A.
- Abstract
Liver δ-aminolevulinic acid synthetase activity was measured in mice living under abnormal atmospheric pressure conditions for 15 h. In the group living under low atmospheric pressure (51 kPa) the enzymic activity, either basal or induced by starvation and/or allylisopropylacetamide, was significantly (p
- Published
- 1985
23. This title is unavailable for guests, please login to see more information.
- Author
-
Yalouris, A.G. Lyberatos, C. Argyropoulos, A. Papasteriadis, E. Raptis, S.A. and Yalouris, A.G. Lyberatos, C. Argyropoulos, A. Papasteriadis, E. Raptis, S.A.
- Published
- 1985
24. Performance of SNP barcodes to determine genetic diversity and population structure of Plasmodium falciparum in Africa
- Author
-
Dionne C. Argyropoulos, Mun Hua Tan, Courage Adobor, Benedicta Mensah, Frédéric Labbé, Kathryn E. Tiedje, Kwadwo A. Koram, Anita Ghansah, and Karen P. Day
- Subjects
malaria ,high-transmission ,molecular surveillance ,population genetics ,Pf6 ,single nucleotide polymorphisms ,Genetics ,QH426-470 - Abstract
Panels of informative biallelic single nucleotide polymorphisms (SNPs) have been proposed to be an economical method to fast-track the population genetic analysis of Plasmodium falciparum in malaria-endemic areas. Whilst used successfully in low-transmission areas where infections are monoclonal and highly related, we present the first study to evaluate the performance of these 24- and 96-SNP molecular barcodes in African countries, characterised by moderate-to-high transmission, where multiclonal infections are prevalent. For SNP barcodes it is generally recommended that the SNPs chosen i) are biallelic, ii) have a minor allele frequency greater than 0.10, and iii) are independently segregating, to minimise bias in the analysis of genetic diversity and population structure. Further, to be standardised and used in many population genetic studies, these barcodes should maintain characteristics i) to iii) across various iv) geographies and v) time points. Using haplotypes generated from the MalariaGEN P. falciparum Community Project version six database, we investigated the ability of these two barcodes to fulfil these criteria in moderate-to-high transmission African populations in 25 sites across 10 countries. Predominantly clinical infections were analysed, with 52.3% found to be multiclonal, generating high proportions of mixed-allele calls (MACs) per isolate thereby impeding haplotype construction. Of the 24- and 96-SNPs, loci were removed if they were not biallelic and had low minor allele frequencies in all study populations, resulting in 20- and 75-SNP barcodes respectively for downstream population genetics analysis. Both SNP barcodes had low expected heterozygosity estimates in these African settings and consequently biased analyses of similarity. Both minor and major allele frequencies were temporally unstable. These SNP barcodes were also shown to identify weak genetic differentiation across large geographic distances based on Mantel Test and DAPC. These results demonstrate that these SNP barcodes are vulnerable to ascertainment bias and as such cannot be used as a standardised approach for malaria surveillance in moderate-to-high transmission areas in Africa, where the greatest genomic diversity of P. falciparum exists at local, regional and country levels.
- Published
- 2023
- Full Text
- View/download PDF
25. Ultrabroadband coherent perfect absorption with composite graphene metasurfaces.
- Author
-
Zou W, Guo T, and Argyropoulos C
- Abstract
We investigate the design and performance of a new multilayer graphene metasurface for achieving ultrabroadband coherent perfect absorption (CPA) in the THz regime. The proposed structure comprises three graphene patterned metasurfaces separated by thin dielectric spacer layers. The top and bottom metasurfaces have crossed shape unit cells of varying sizes, while the middle graphene metasurface is square-shaped. This distinctive geometrical asymmetry and the presence of multiple layers within the structure facilitate the achievement of wideband asymmetric reflection under incoherent illumination. This interesting property serves as a crucial step towards achieving near-total absorption under coherent illumination across a broad frequency range. Numerical simulations demonstrate that the absorption efficiency surpasses 90% across an ultrabroadband frequency range from 2.8 to 5.7 THz, i.e., a bandwidth of 2.9 THz. The CPA effect can be selectively tuned by manipulating the phase difference between the two incident coherent beams. Moreover, the absorption response can be dynamically adjusted by altering the Fermi level of graphene. The study also examines the influence of geometric parameters on the absorption characteristics. The results of this research work offer valuable insights into the design of broadband graphene metasurfaces for coherent absorption applications, and they contribute to the advancement of sophisticated optical devices operating in the THz frequency range.
- Published
- 2024
- Full Text
- View/download PDF
26. Peritoneal Dialysis Technique Survival: A Cohort Study.
- Author
-
Hsu CM, Li NC, Lacson EK Jr, Weiner DE, Paine S, Majchrzak K, Argyropoulos C, Roumelioti ME, Pankratz VS, Miskulin D, Manley HJ, Salenger P, Johnson D, Johnson HK, and Harford A
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Aged, Cohort Studies, Renal Dialysis methods, Adult, Time Factors, Peritoneal Dialysis methods, Kidney Failure, Chronic therapy
- Abstract
Rationale & Objective: Reasons for transfer from peritoneal dialysis (PD) to hemodialysis (HD) remain incompletely understood. Among incident and prevalent patients receiving PD, we evaluated the association of clinical factors, including prior treatment with HD, with PD technique survival., Study Design: Retrospective cohort study., Setting & Participants: Adults who initiated PD at a Dialysis Clinic, Inc (DCI) outpatient facility between January 1, 2010, and September 30, 2019., Exposure: The primary exposure of interest was timing of PD start, categorized as PD-first, PD-early, or PD-late. Other covariates included demographics, clinical characteristics, and routine laboratory results., Outcome: Modality switch from PD to HD sustained for more than 90 days., Analytical Approach: Multivariable Fine-Gray models with competing risks and time-varying covariates, stratified at 9 months to account for lack of proportionality., Results: Among 5,224 patients who initiated PD at a DCI facility, 3,174 initiated dialysis with PD ("PD-first"), 942 transitioned from HD to PD within 90 days ("PD-early"), and 1,108 transitioned beyond 90 days ("PD-late"); 1,472 (28%) subsequently transferred from PD to HD. The PD-early and PD-late patients had a higher risk of transfer to HD as compared with PD-first patients (in the first 9 months: adjusted hazard ratio [AHR], 1.51 [95% CI, 1.17-1.96] and 2.41 [95% CI, 1.94-3.00], respectively; and after 9 months: AHR, 1.16 [95% CI, 0.99-1.35] and AHR, 1.43 [95% CI, 1.24-1.65], respectively). More peritonitis episodes, fewer home visits, lower serum albumin levels, lower residual kidney function, and lower peritoneal clearance calculated with weekly Kt/V were additional risk factors for PD-to-HD transfer., Limitations: Missing data on dialysis adequacy and residual kidney function, confounded by short PD technique survival., Conclusions: Initiating dialysis with PD is associated with greater PD technique survival, though many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower Kt/V are risk factors for PD-to-HD transfer that may be amenable to intervention., Plain-Language Summary: Peritoneal dialysis (PD) is an important kidney replacement modality with several potential advantages compared with in-center hemodialysis (HD). However, a substantial number of patients transfer to in-center HD early on, without having experienced the quality-of-life and other benefits that come with sustained maintenance of PD. Using retrospective data from a midsize national dialysis provider, we found that initiating dialysis with PD is associated with longer maintenance of PD, compared with initiating dialysis with HD and a later switch to PD. However, many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower small protein removal are other risk factors for PD-to-HD transfer that may be amenable to intervention., (Copyright © 2024 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
27. Chiroptical Second-Harmonic Tyndall Scattering from Silicon Nanohelices.
- Author
-
Olohan BJ, Petronijevic E, Kilic U, Wimer S, Hilfiker M, Schubert M, Argyropoulos C, Schubert E, Clowes SR, Pantoş GD, Andrews DL, and Valev VK
- Abstract
Chirality is omnipresent in the living world. As biomimetic nanotechnology and self-assembly advance, they too need chirality. Accordingly, there is a pressing need to develop general methods to characterize chiral building blocks at the nanoscale in liquids such as water─the medium of life. Here, we demonstrate the chiroptical second-harmonic Tyndall scattering effect. The effect was observed in Si nanohelices, an example of a high-refractive-index dielectric nanomaterial. For three wavelengths of illumination, we observe a clear difference in the second-harmonic scattered light that depends on the chirality of the nanohelices and the handedness of circularly polarized light. Importantly, we provide a theoretical analysis that explains the origin of the effect and its direction dependence, resulting from different specific contributions of "electric dipole-magnetic dipole" and "electric dipole-electric quadrupole" coupling tensors. Using numerical simulations, we narrow down the number of such terms to 8 in forward scattering and to a single one in right-angled scattering. For chiral scatterers such as high-refractive-index dielectric nanoparticles, our findings expand the Tyndall scattering regime to nonlinear optics. Moreover, our theory can be broadened and adapted to further classes where such scattering has already been observed or is yet to be observed.
- Published
- 2024
- Full Text
- View/download PDF
28. Controlling the broadband enhanced light chirality with L-shaped dielectric metamaterials.
- Author
-
Kilic U, Hilfiker M, Wimer S, Ruder A, Schubert E, Schubert M, and Argyropoulos C
- Abstract
The inherently weak chiroptical responses of natural materials limit their usage for controlling and enhancing chiral light-matter interactions. Recently, several nanostructures with subwavelength scale dimensions were demonstrated, mainly due to the advent of nanofabrication technologies, as a potential alternative to efficiently enhance chirality. However, the intrinsic lossy nature of metals and the inherent narrowband response of dielectric planar thin films or metasurface structures pose severe limitations toward the practical realization of broadband and tailorable chiral systems. Here, we tackle these problems by designing all-dielectric silicon-based L-shaped optical metamaterials based on tilted nanopillars that exhibit broadband and enhanced chiroptical response in transmission operation. We use an emerging bottom-up fabrication approach, named glancing angle deposition, to assemble these dielectric metamaterials on a wafer scale. The reported strong chirality and optical anisotropic properties are controllable in terms of both amplitude and operating frequency by simply varying the shape and dimensions of the nanopillars. The presented nanostructures can be used in a plethora of emerging nanophotonic applications, such as chiral sensors, polarization filters, and spin-locked nanowaveguides., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. Chronic Kidney Disease in the Older Adult Patient with Diabetes.
- Author
-
Ravender R, Roumelioti ME, Schmidt DW, Unruh ML, and Argyropoulos C
- Abstract
Diabetes mellitus (DM) and chronic kidney disease (CKD) are common in middle aged and older adult individuals. DM may accelerate the aging process, and the age-related declines in the estimated glomerular filtration rate (eGFR) can pose a challenge to diagnosing diabetic kidney disease (DKD) using standard diagnostic criteria especially with the absence of severe albuminuria among older adults. In the presence of CKD and DM, older adult patients may need multidisciplinary care due to susceptibility to various health issues, e.g., cognitive decline, auditory or visual impairment, various comorbidities, complex medical regimens, and increased sensitivity to medication adverse effects. As a result, it can be challenging to apply recent therapeutic advancements for the general population to older adults. We review the evidence that the benefits from these newer therapies apply equally to older and younger patients with CKD and diabetes type 2 and propose a comprehensive management. This framework will address nonpharmacological measures and pharmacological management with renin angiotensin system inhibitors (RASi), sodium glucose co-transporter 2 inhibitors (SGLT2i), non-steroidal mineralocorticoids receptor antagonists (MRAs), and glucagon like peptide 1 receptor agonists (GLP1-RAs).
- Published
- 2024
- Full Text
- View/download PDF
30. A closer look at weight loss interventions in primary care: a systematic review and meta-analysis.
- Author
-
Perreault L, Kramer ES, Smith PC, Schmidt D, and Argyropoulos C
- Abstract
Purpose: The major aims were to quantify patient weight loss using various approaches adminstered by a primary care provider for at least 6 months and to unveil relevant contextual factors that could improve patient weight loss on a long-term basis., Methods: A systematic review and meta-analysis was conducted using Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Scopus, and Web of Science from inception to December 5, 2022. COVIDENCE systematic review software was used to identify and abstract data, as well as assess data quality and risk of bias., Results: Seven studies included 2,187 people with obesity testing (1) anti-obesity medication (AOM), (2) AOM, intensive lifestyle counseling + meal replacements, and (3) physician training to better counsel patients on intensive lifestyle modification. Substantial heterogeneity in the outcomes was observed, as well as bias toward lack of published studies showing no effect. The random effect model estimated a treatment effect for the aggregate efficacy of primary care interventions -3.54 kg (95% CI: -5.61 kg to -1.47 kg). Interventions that included a medication component (alone or as part of a multipronged intervention) achieved a greater weight reduction by -2.94 kg ( p < 0.0001). In all interventions, efficacy declined with time (reduction in weight loss by 0.53 kg per 6 months, 95% CI: 0.04-1.0 kg)., Conclusion: Weight loss interventions administered by a primary care provider can lead to modest weight loss. Weight loss is approximately doubled if anti-obesity medication is part of the treatment. Nevertheless, attenuated weight loss over time underscores the need for long-term treatment., Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/ CRD4202121242344], identifier (CRD42021242344)., Competing Interests: LP has received personal fees for speaking and/or consulting from Novo Nordisk, Sanofi, Boehringer Ingelheim, Elli Lilly, Bayer, Neurobo, Medscape, WebMD and UpToDate. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Perreault, Kramer, Smith, Schmidt and Argyropoulos.)
- Published
- 2023
- Full Text
- View/download PDF
31. Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.
- Author
-
Hsu CM, Weiner DE, Manley HJ, Li NC, Miskulin D, Harford A, Sanders R, Ladik V, Frament J, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, and Lacson EK Jr
- Abstract
Rationale & Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are likely underdiagnosed, but the degree of underdiagnosis among patients receiving maintenance dialysis is unknown. The durability of the immune response after the third vaccine dose in this population also remains uncertain. This descriptive study tracked antibody levels to (1) assess the rate of undiagnosed infections and (2) characterize seroresponse durability after the third dose., Study Design: Retrospective observational study., Setting & Participants: SARS-CoV-2-vaccinated patients receiving maintenance dialysis through a national dialysis provider. Immunoglobulin G spike antibodies [anti-spike immunoglobulin (Ig) G] titers were assessed monthly after vaccination., Exposures: Two and 3 doses of SARS-CoV-2 vaccine., Outcomes: Undiagnosed and diagnosed SARS-CoV-2 infections; anti-spike IgG titers over time., Analytical Approach: Undiagnosed SARS-CoV-2 infections were identified as an increase in anti-spike IgG titer of ≥100 BAU/mL, not associated with receipt of vaccine or diagnosed SARS-CoV-2 infection (by polymerase chain reaction test or antigen test). In descriptive analyses, anti-spike IgG titers were followed over time., Results: Among 2,703 patients without previous coronavirus disease 2019 (COVID-19) who received an initial 2-dose vaccine series, 271 had diagnosed SARS-CoV-2 infections (3.4 per 10,000 patient-days) and 129 had undiagnosed SARS-CoV-2 infections (1.6 per 10,000 patient-days). Among 1,894 patients without previous COVID-19 who received a third vaccine dose, 316 had diagnosed SARS-CoV-2 infections (7.0 per 10,000 patient-days) and 173 had undiagnosed SARS-CoV-2 infections (3.8 per 10,000 patient-days). In both cohorts, anti-spike IgG levels declined over time. Of the initial 2-dose cohort, 66% had a titer of ≥500 BAU/mL in the first month, with 24% maintaining a titer of ≥500 BAU/mL at 6 months. Of the third dose cohort, 95% had a titer of ≥500 BAU/mL in the first month after the third dose, with 77% maintaining a titer of ≥500 BAU/mL at 6 months., Limitations: The assays used had upper limits., Conclusions: Among patients receiving maintenance dialysis, about 1 in every 3 SARS-CoV-2 infections was undiagnosed. Given this population's vulnerability to COVID-19, ongoing infection control measures are needed. A 3-dose primary mRNA vaccine series optimizes seroresponse rate and durability., Plain-Language Summary: Patients receiving maintenance dialysis have been particularly vulnerable to COVID-19. Using serially measured antibodies, we found that a substantial proportion (about one-third) of SARS-CoV-2 infections among this population had been missed, both among those who had completed a 2-dose vaccine series and among those who had received a third vaccine dose. Such missed infections likely had only mild or minimal symptoms, but this failure to recognize all infections is concerning. Furthermore, vaccines have been effective among patients receiving dialysis, but our study additionally shows that the immune response wanes over time, even after a third dose. There is therefore a role for ongoing vigilance against this highly transmissible infection., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
32. An Introduction to Nanopore Sequencing: Past, Present, and Future Considerations.
- Author
-
MacKenzie M and Argyropoulos C
- Abstract
There has been significant progress made in the field of nanopore biosensor development and sequencing applications, which address previous limitations that restricted widespread nanopore use. These innovations, paired with the large-scale commercialization of biological nanopore sequencing by Oxford Nanopore Technologies, are making the platforms a mainstay in contemporary research laboratories. Equipped with the ability to provide long- and short read sequencing information, with quick turn-around times and simple sample preparation, nanopore sequencers are rapidly improving our understanding of unsolved genetic, transcriptomic, and epigenetic problems. However, there remain some key obstacles that have yet to be improved. In this review, we provide a general introduction to nanopore sequencing principles, discussing biological and solid-state nanopore developments, obstacles to single-base detection, and library preparation considerations. We present examples of important clinical applications to give perspective on the potential future of nanopore sequencing in the field of molecular diagnostics.
- Published
- 2023
- Full Text
- View/download PDF
33. Tunable directional filter for mid-infrared optical transmission switching.
- Author
-
Butler A, Schulz J, and Argyropoulos C
- Abstract
Controlling the spectral and angular response of infrared (IR) radiation is a challenging task of paramount importance to various emerging photonic applications. Here, we overcome these problems by proposing and analyzing a new design of a tunable narrowband directional optical transmission filter. The presented thermally controlled multilayer filter leverages the temperature dependent phase change properties of vanadium dioxide (VO
2 ) to enable efficient and reversible fast optical switching by using a pump-probe laser excitation setup. More specifically, transmission is blocked for high intensity probe lasers due to the VO2 metallic properties induced at elevated temperatures while at low probe laser intensities high transmission through the filter occurs only for a narrowband IR range confined to near normal incident angles. The proposed multilayer composite dielectric filter is expected to have applications in optical communications, where it can act as dual functional infrared filter and optical switch.- Published
- 2022
- Full Text
- View/download PDF
34. Bubble growth analysis during subcooled boiling experiments on-board the international space station: Benchmark image analysis.
- Author
-
Oikonomidou O, Evgenidis S, Argyropoulos C, Zabulis X, Karamaoynas P, Raza MQ, Sebilleau J, Ronshin F, Chinaud M, Garivalis AI, Kostoglou M, Sielaff A, Schinnerl M, Stephan P, Colin C, Tadrist L, Kabov O, Di Marco P, and Karapantsios T
- Abstract
This work compares four different image processing algorithms for the analysis of image data obtained during the Multiscale Boiling Experiment of ESA, executed on-board the International Space Station. Two separate experimental campaigns have been performed in 2019 and 2020, aiming to investigate boiling phenomena in microgravity, with and without the presence of shear flow and electric field. A heated substrate, at the bottom of the test cell, creates a temperature profile across the liquid bulk above it. A laser beam hits a designated microcavity at the middle of the substrate, to initiate nucleation of a single, isolated bubble. In the presence of shear flow or electric field forces, the bubble slides or detaches respectively, leaving the cavity free for the nucleation and growth of a new bubble. The growth of such a bubble within the prescribed temperature profile is studied for varying experimental conditions (i.e. pressure, heat flux, subcooling temperature) by capturing high speed, black and white video images. The presence of light reflections at random locations around the bubble contour vary with bubble size and population. This, combined with the refraction induced optical distortion of vertical image dimension close to the heater, make the accurate detection of bubbles contour a real challenge. Four research teams, namely the University of Pisa (UNIPI), the Institute of Fluid Mechanics of Toulouse (IMFT), the joint group of Aix Marseille University (AMU) and Kutateladze Institute of Thermophysics (IT), and the joined group of Aristotle University of Thessaloniki (AUTH), Technical University of Darmstadt (TUD) and Foundation of Research and Technology in Crete (FORTH), developed separate specialized algorithms to: a) detect bubble edges and b) use these edges to calculate basic bubble geometrical features, such as contact line diameter, bubble diameter and contact angles. These four different approaches diverge in complexity and concept. In the absence of reference measurements at microgravity conditions, measurements efficiency is evaluated based on the comparison of the estimated bubble geometrical features along with pertinent physical arguments. Results show that the efficiency of each approach varies with the nature of measurement. The studied benchmark dataset is published allowing other research groups to test further their own image processing algorithms., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
35. Nonlinear Strong Coupling by Second-Harmonic Generation Enhancement in Plasmonic Nanopatch Antennas.
- Author
-
Krause B, Mishra D, Chen J, Argyropoulos C, and Hoang T
- Abstract
Enhanced electromagnetic fields within plasmonic nanocavity mode volumes enable multiple significant effects that lead to applications in both the linear and nonlinear optical regimes. In this work, we demonstrate enhanced second harmonic generation from individual plasmonic nanopatch antennas which are formed by separating silver nanocubes from a smooth gold film using a sub-10 nm zinc oxide spacer layer. When the nanopatch antennas are excited at their fundamental plasmon frequency, a 10
4 -fold increase in the intensity of the second harmonic generation wave is observed. Moreover, by integrating quantum emitters that have an absorption energy at the fundamental frequency, a second order nonlinear exciton - polariton strong coupling response is observed with a Rabi splitting energy of 19 meV. The nonlinear frequency conversion using nanopatch antennas thus provides an excellent platform for nonlinear control of the light-matter interactions in both weak and strong coupling regimes which will have a great potential for applications in optical engineering and information processing., Competing Interests: Conflict of Interests The authors declare no conflict of interest.- Published
- 2022
- Full Text
- View/download PDF
36. Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD.
- Author
-
Hiremath S, McGuinty M, Argyropoulos C, Brimble KS, Brown PA, Chagla Z, Cooper R, Hoar S, Juurlink D, Treleaven D, Walsh M, Yeung A, and Blake P
- Subjects
- Humans, Renal Dialysis, Ritonavir therapeutic use, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic drug therapy, COVID-19 Drug Treatment
- Published
- 2022
- Full Text
- View/download PDF
37. Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease.
- Author
-
Tuttle KR, Wong L, St Peter W, Roberts G, Rangaswami J, Mottl A, Kliger AS, Harris RC, Gee PO, Fowler K, Cherney D, Brosius FC 3rd, Argyropoulos C, and Quaggin SE
- Subjects
- Angiotensin Receptor Antagonists therapeutic use, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Humans, Mineralocorticoid Receptor Antagonists therapeutic use, Diabetes Mellitus, Type 2 drug therapy, Diabetic Nephropathies diagnosis, Diabetic Nephropathies drug therapy, Diabetic Nephropathies etiology, Renal Insufficiency
- Abstract
Diabetic kidney disease is the most frequent cause of kidney failure, accounting for half of all cases worldwide. Moreover, deaths from diabetic kidney disease increased 106% between 1990 and 2013, with most attributed to cardiovascular disease. Recommended screening and monitoring for diabetic kidney disease are conducted in less than half of patients with diabetes. Standard-of-care treatment with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker is correspondingly low. Sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and a nonsteroidal mineralocorticoid antagonist are highly effective therapies to reduce kidney and cardiovascular risks in diabetic kidney disease. However, <20% of eligible patients are receiving these agents. Critical barriers are high out-of-pocket drug costs and low reimbursement rates. Data demonstrating clinical and cost-effectiveness of diabetic kidney disease care are needed to garner payer and health care system support. The pharmaceutical industry should collaborate on value-based care by increasing access through affordable drug prices. Additionally, multidisciplinary models and communication technologies tailored to individual health care systems are needed to support optimal diabetic kidney disease care. Community outreach efforts are also central to make care accessible and equitable. Finally, it is imperative that patient preferences and priorities shape implementation strategies. Access to care and implementation of breakthrough therapies for diabetic kidney disease can save millions of lives by preventing kidney failure, cardiovascular events, and premature death. Coalitions composed of patients, families, community groups, health care professionals, health care systems, federal agencies, and payers are essential to develop collaborative models that successfully address this major public health challenge., (Copyright © 2022 by the American Society of Nephrology.)
- Published
- 2022
- Full Text
- View/download PDF
38. Protocol for the IMPACT Trial: Improving Healthcare Outcomes in American Transplant Recipients Using Culturally-Tailored Novel Technology.
- Author
-
Rice CM, Singh PP, Judd NS, Jimenez EY Dr, Blair CK, Washburn A, Calvin C, Steiber A Dr, Zhu Y, Argyropoulos C, Unruh M, Dew MA, and Myaskovsky L
- Subjects
- Delivery of Health Care, Humans, Technology, Weight Gain, Quality of Life, Transplant Recipients
- Abstract
Kidney transplant (KT) recipients face post-transplant health issues. Immunosuppressive agents can cause hyperlipidemia, hypertension, post-transplant diabetes, and glomerulopathy. Post-transplant weight gain and decreased activity are associated with poor quality of life, sleep, and cardiometabolic outcomes. This study will test the feasibility and acceptability of a culturally tailored diet and exercise intervention for KT patients delivered immediately post-transplant using novel technology. A registered dietitian nutritionist (RDN) and physical rehabilitation therapist will examine participants' cultural background, preferences, and health-related obstacles (with consultation from the transplant team) to create an individualized exercise and meal plan. The RDN will provide medical nutrition therapy via the nutrition care process throughout the course of the intervention. The Twistle Patient Engagement Platform will be used to deliver and collect survey data, communicate with participants, and promote retention. Outcomes to be assessed include intervention feasibility and acceptability and intervention efficacy on patients' adherence, medical, quality of life, and occupational outcomes., (Copyright © 2022 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
39. Unraveling the temperature dynamics and hot electron generation in tunable gap-plasmon metasurface absorbers.
- Author
-
Khosravi Khorashad L and Argyropoulos C
- Abstract
Localized plasmons formed in ultrathin metallic nanogaps can lead to robust absorption of incident light. Plasmonic metasurfaces based on this effect can efficiently generate energetic charge carriers, also known as hot electrons, owing to their ability to squeeze and enhance electromagnetic fields in confined subwavelength spaces. However, it is very challenging to accurately identify and quantify the dynamics of hot carriers, mainly due to their ultrafast time decay. Their nonequilibrium temperature response is one of the key factors missing to understand the short time decay and overall transient tunable absorption performance of gap-plasmon metasurfaces. Here, we systematically study the temperature dynamics of hot electrons and their transition into thermal carriers at various timescales from femto to nanoseconds by using the two-temperature model. Additionally, the hot electron temperature and generation rate threshold values are investigated by using a hydrodynamic nonlocal model approach that is more accurate when ultrathin gaps are considered. The derived temperature dependent material properties are used to study the ultrafast transient nonlinear modification in the absorption spectrum before plasmon-induced lattice heating is established leading to efficient tunable nanophotonic absorber designs. We also examine the damage threshold of these plasmonic absorbers under various pulsed laser illuminations, an important quantity to derive the ultimate input intensity limits that can be used in various emerging nonlinear optics and other tunable nanophotonic applications. The presented results elucidate the role of hot electrons in the response of gap-plasmon metasurface absorbers which can be used to design more efficient photocatalysis, photovoltaics, and photodetection devices., (© 2022 Larousse Khosravi Khorashad and Christos Argyropoulos, published by De Gruyter, Berlin/Boston.)
- Published
- 2022
- Full Text
- View/download PDF
40. Video Images about Decisions for Ethical Outcomes in Kidney Disease (VIDEO-KD): the study protocol for a multi-centre randomised controlled trial.
- Author
-
Eneanya ND, Lakin JR, Paasche-Orlow MK, Lindvall C, Moseley ET, Henault L, Hanchate AD, Mandel EI, Wong SPY, Zupanc SN, Davis AD, El-Jawahri A, Quintiliani LM, Chang Y, Waikar SS, Bansal AD, Schell JO, Lundquist AL, Tamura MK, Yu MK, Unruh ML, Argyropoulos C, Germain MJ, and Volandes A
- Subjects
- Aged, Humans, Multicenter Studies as Topic, Quality of Life, Randomized Controlled Trials as Topic, Renal Dialysis, Advance Care Planning, Renal Insufficiency, Chronic therapy, Terminal Care
- Abstract
Introduction: Older patients with advanced chronic kidney disease (CKD) often are inadequately prepared to make informed decisions about treatments including dialysis and cardiopulmonary resuscitation. Further, evidence shows that patients with advanced CKD do not commonly engage in advance care planning (ACP), may suffer from poor quality of life, and may be exposed to end-of-life care that is not concordant with their goals. We aim to study the effectiveness of a video intervention on ACP, treatment preferences and other patient-reported outcomes., Methods and Analysis: The Video Images about Decisions for Ethical Outcomes in Kidney Disease trial is a multi-centre randomised controlled trial that will test the effectiveness of an intervention that includes a CKD-related video decision aid followed by recording personal video declarations about goals of care and treatment preferences in older adults with advancing CKD. We aim to enrol 600 patients over 5 years at 10 sites., Ethics and Dissemination: Regulatory and ethical aspects of this trial include a single Institutional Review Board mechanism for approval, data use agreements among sites, and a Data Safety and Monitoring Board. We intend to disseminate findings at national meetings and publish our results., Trial Registration Number: NCT04347629., Competing Interests: Competing interests: NE is a scientific advisor for Somatus and Davita. MKT has received honoraria from the American Federation of Aging Research and serves as Associate Editor at CJASN. Views expressed are those of the authors and not necessarily those of the Department of Veterans Affairs. AV has a financial interest in ACP decisions, a non-profit organisation developing advance care planning video decision support tools. AV’s interests were reviewed and are managed by MGH and Mass General Brigham in accordance with their conflict-of-interest policies. No other disclosures to report., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
41. Tunable SERS Enhancement via Sub-nanometer Gap Metasurfaces.
- Author
-
Bauman SJ, Darweesh AA, Furr M, Magee M, Argyropoulos C, and Herzog JB
- Abstract
Raman sensing is a powerful technique for detecting chemical signatures, especially when combined with optical enhancement techniques such as using substrates containing plasmonic nanostructures. In this work, we successfully demonstrated surface-enhanced Raman spectroscopy (SERS) of two analytes adsorbed onto gold nanosphere metasurfaces with tunable subnanometer gap widths. These metasurfaces, which push the bounds of previously studied SERS nanostructure feature sizes, were fabricated with precise control of the intersphere gap width to within 1 nm for gaps close to and below 1 nm. Analyte Raman spectra were measured for samples for a range of gap widths, and the surface-affected signal enhancement was found to increase with decreasing gap width, as expected and corroborated via electromagnetic field modeling. Interestingly, an enhancement quenching effect was observed below gaps of around 1 nm. We believe this to be one of the few studies of gap-width-dependent SERS for the subnanometer range, and the results suggest the potential of such methods as a probe of subnanometer scale effects at the interface between plasmonic nanostructures. With further study, we believe that tunable sub-nanometer gap metasurfaces could be a useful tool for the study of nonlocal and quantum enhancement-quenching effects. This could aid the development of optimized Raman-based sensors for a variety of applications.
- Published
- 2022
- Full Text
- View/download PDF
42. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
- Author
-
Mottl AK, Alicic R, Argyropoulos C, Brosius FC, Mauer M, Molitch M, Nelson RG, Perreault L, and Nicholas SB
- Subjects
- Humans, Hypoglycemic Agents therapeutic use, Kidney, Diabetes Mellitus, Nephrology, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic therapy, Sodium-Glucose Transporter 2 Inhibitors therapeutic use
- Abstract
In October 2020, KDIGO (Kidney Disease: Improving Global Outcomes) published its first clinical practice guideline directed specifically to the care of patients with diabetes and chronic kidney disease (CKD). This commentary presents the views of the KDOQI (Kidney Disease Outcomes Quality Initiative) work group for diabetes in CKD, convened by the National Kidney Foundation to provide an independent expert perspective on the new guideline. The KDOQI work group believes that the KDIGO guideline takes a major step forward in clarifying glycemic targets and use of specific antihyperglycemic agents in diabetes and CKD. The purpose of this commentary is to carry forward the conversation regarding optimization of care for patients with diabetes and CKD. Recent developments for prevention of CKD progression and cardiovascular events in people with diabetes and CKD, particularly related to sodium/glucose cotransporter 2 (SGLT2) inhibitors, have filled a longstanding gap in nephrology's approach to the care of persons with diabetes and CKD. The multifaceted benefits of SGLT2 inhibitors have facilitated interactions between nephrology, cardiology, endocrinology, and primary care, underscoring the need for innovative approaches to multidisciplinary care in these patients. We now have more interventions to slow kidney disease progression and prevent or delay kidney failure in patients with diabetes and kidney disease, but methods to streamline their implementation and overcome barriers in access to care, particularly cost, are essential to ensuring all patients may benefit., (Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
43. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
- Author
-
Hsu CM, Weiner DE, Manley HJ, Aweh GN, Ladik V, Frament J, Miskulin D, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, and Lacson EK Jr
- Subjects
- 2019-nCoV Vaccine mRNA-1273 administration & dosage, 2019-nCoV Vaccine mRNA-1273 immunology, Aged, Aged, 80 and over, BNT162 Vaccine administration & dosage, BNT162 Vaccine immunology, Biomarkers blood, COVID-19 immunology, COVID-19 virology, COVID-19 Vaccines immunology, Female, Humans, Immunocompromised Host, Male, Middle Aged, Renal Insufficiency, Chronic immunology, Retrospective Studies, Spike Glycoprotein, Coronavirus immunology, Time Factors, Treatment Outcome, United States, Vaccine Efficacy, Antibodies, Viral blood, COVID-19 prevention & control, COVID-19 Vaccines administration & dosage, Immunogenicity, Vaccine, Immunoglobulin G blood, Renal Dialysis adverse effects, Renal Insufficiency, Chronic therapy, SARS-CoV-2 immunology, Vaccination
- Abstract
Background and Objectives: Although most patients receiving maintenance dialysis exhibit initial seroresponse to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, concerns exist regarding the durability of this antibody response. This study evaluated seroresponse over time., Design, Setting, Participants, & Measurements: This retrospective cohort study included patients on maintenance dialysis, from a midsize national dialysis provider, who received a complete SARS-CoV-2 vaccine series and had at least one antibody titer checked after full vaccination. IgG spike antibodies (anti-spike IgG) titers were assessed monthly with routine laboratory tests after vaccination; the semiquantitative assay reported a range between zero and ≥20 Index. Descriptive analyses compared trends over time by history of coronavirus disease 2019 (COVID-19) and vaccine type. Time-to-event analyses examined the outcome of loss of seroresponse (anti-spike IgG <1 Index or development of COVID-19). Cox regression adjusted for additional clinical characteristics., Results: Among 1870 patients receiving maintenance dialysis, 1569 had no prior COVID-19. Patients without prior COVID-19 had declining titers over time. Among 443 recipients of BNT162b2 (Pfizer), median (interquartile range) anti-spike IgG titer declined from ≥20 (5.89 to ≥20) in month 1 after full vaccination to 1.96 (0.60-5.88) by month 6. Among 778 recipients of mRNA-1273 (Moderna), anti-spike IgG titer declined from ≥20 (interquartile range, ≥20 to ≥20) in month 1 to 7.99 (2.61 to ≥20) by month 6. The 348 recipients of Ad26.COV2.S (Janssen) had a lower titer response than recipients of an mRNA vaccine over all time periods. In time-to-event analyses, recipients of Ad26.COV2.S and mRNA-1273 had the shortest and longest time to loss of seroresponse, respectively. The maximum titer reached in the first 2 months after full vaccination was associated with durability of the anti-spike IgG seroresponse; patients with anti-spike IgG titer 1-19.99 had a shorter time to loss of seroresponse compared with patients with anti-spike IgG titer ≥20 (hazard ratio, 15.5; 95% confidence interval, 11.7 to 20.7)., Conclusions: Among patients receiving maintenance dialysis, vaccine-induced seroresponse wanes over time across vaccine types. Early titers after full vaccination are associated with the durability of seroresponse., (Copyright © 2022 by the American Society of Nephrology.)
- Published
- 2022
- Full Text
- View/download PDF
44. Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients.
- Author
-
Hsu CM, Weiner DE, Aweh GN, Manley HJ, Ladik V, Frament J, Miskulin D, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, and Lacson EK
- Subjects
- Humans, Immunogenicity, Vaccine, Renal Dialysis, SARS-CoV-2, COVID-19, COVID-19 Vaccines
- Published
- 2022
- Full Text
- View/download PDF
45. Efficient single-photon pair generation by spontaneous parametric down-conversion in nonlinear plasmonic metasurfaces.
- Author
-
Jin B, Mishra D, and Argyropoulos C
- Abstract
Spontaneous parametric down-conversion (SPDC) is one of the most versatile nonlinear optical techniques for the generation of entangled and correlated single-photon pairs. However, it suffers from very poor efficiency leading to extremely weak photon generation rates. Here we propose a plasmonic metasurface design based on silver nanostripes combined with a bulk lithium niobate (LiNbO
3 ) crystal to realize a new scalable, ultrathin, and efficient SPDC source. By coinciding fundamental and higher order resonances of the metasurface with the generated signal and idler frequencies, respectively, the electric field in the nonlinear media is significantly boosted. This leads to a substantial enhancement in the SPDC process which, subsequently, by using the quantum-classical correspondence principle, translates to very high photon-pair generation rates. The emitted radiation is highly directional and perpendicular to the metasurface in contrast to relevant dielectric structures. The incorporation of circular polarized excitation further increases the photon-pair generation efficiency. The presented work will lead to the design of new efficient ultrathin SPDC single-photon nanophotonic sources working at room temperature that are expected to be critical components in free-space quantum optical communications. In a more general context, our findings can have various applications in the emerging field of quantum plasmonics.- Published
- 2021
- Full Text
- View/download PDF
46. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.
- Author
-
Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, and Hiremath S
- Abstract
The effects of the coronavirus disease-2019 (COVID-19) pandemic, particularly among those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD, including those receiving dialysis or with a kidney transplant. We found 35 studies (28 published, 7 preprints), with sample sizes ranging from 23 to 1140 participants and follow-up ranging from 1 week to 1 month after vaccination. Seventeen of these studies enrolled a control group. In the 22 studies of patients receiving dialysis, the development of antibodies was observed in 18% to 53% after 1 dose and in 70% to 96% after 2 doses of mRNA vaccine. In the 14 studies of transplant recipients, 3% to 59% mounted detectable humoral or cellular responses after 2 doses of mRNA vaccine. After vaccination, there were a few reported cases of relapse or de novo glomerulonephritis, and acute transplant rejection, suggesting a need for ongoing surveillance. Studies are needed to better evaluate the effectiveness of SARS-CoV-2 vaccination in these populations. Rigorous surveillance is necessary for detection of long-term adverse effects in patients with autoimmune disease and transplant recipients. For transplant recipients and those with suboptimal immune responses, alternate vaccination platforms and strategies should be considered. As additional data arise, the NephJC COVID-19 page will continue to be updated (http://www.nephjc.com/news/covid-vaccine)., (© 2021 International Society of Nephrology. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
47. Reconsidering Donor Race in Predicting Allograft and Patient Survival Among Kidney Transplant Recipients.
- Author
-
Chong K, Litvinovich I, Chen SS, Zhu Y, Argyropoulos C, and Ng YH
- Subjects
- Allografts, Graft Survival, Humans, Retrospective Studies, Kidney Failure, Chronic, Kidney Transplantation adverse effects
- Abstract
Donor race should not be used in models to predict allograft and patient survival.Removing donor race from the Kidney Donor Risk Index may reduce kidney discard by reclassifying approximately 50% of high kidney donor profile index kidneys.Future prediction models should focus on using relevant biologic factors rather than social constructs when trying to predict outcomes., Competing Interests: C. Argyropoulos reports having consultancy agreements with Alkahest and Momenta Pharma; reports receiving research funding from Dialysis Clinic Inc. and the University of Pennsylvania; reports being a scientific advisor or member of Baxter Healthcare, Bayer, and Health Services Advisory Group; and reports other interests/relationships with AbbVie as Sub-I in a phase 3 study of an experimental agent in diabetic nephropathy, Akebia principal investigator in two phase 3 trials of an investigational product for the correction and maintenance of anemia in patients with nondialysis-dependent CKD and one phase 3 study of the same agent in dialysis, Dialysis Clinic Inc. as Medical Director of the Outpatient Dialysis Unit in Cuba, New Mexico, and the Dialysis Outcomes and Practice Patterns Program, principal investigator for CKD-DOPP. Y. Zhu reports receiving research funding from Dialysis Clinic Inc., Patient-Centered Outcomes Research Institute, the National Institutes of Health, and US Department of State. All remaining authors have nothing to disclose., (Copyright © 2021 by the American Society of Nephrology.)
- Published
- 2021
- Full Text
- View/download PDF
48. High performance implementation of the hierarchical likelihood for generalized linear mixed models: an application to estimate the potassium reference range in massive electronic health records datasets.
- Author
-
Bologa CG, Pankratz VS, Unruh ML, Roumelioti ME, Shah V, Shaffi SK, Arzhan S, Cook J, and Argyropoulos C
- Subjects
- Bayes Theorem, Humans, Linear Models, Markov Chains, Monte Carlo Method, Reference Values, Electronic Health Records, Potassium
- Abstract
Background: Converting electronic health record (EHR) entries to useful clinical inferences requires one to address the poor scalability of existing implementations of Generalized Linear Mixed Models (GLMM) for repeated measures. The major computational bottleneck concerns the numerical evaluation of multivariable integrals, which even for the simplest EHR analyses may involve millions of dimensions (one for each patient). The hierarchical likelihood (h-lik) approach to GLMMs is a methodologically rigorous framework for the estimation of GLMMs that is based on the Laplace Approximation (LA), which replaces integration with numerical optimization, and thus scales very well with dimensionality., Methods: We present a high-performance, direct implementation of the h-lik for GLMMs in the R package TMB. Using this approach, we examined the relation of repeated serum potassium measurements and survival in the Cerner Real World Data (CRWD) EHR database. Analyzing this data requires the evaluation of an integral in over 3 million dimensions, putting this problem beyond the reach of conventional approaches. We also assessed the scalability and accuracy of LA in smaller samples of 1 and 10% size of the full dataset that were analyzed via the a) original, interconnected Generalized Linear Models (iGLM), approach to h-lik, b) Adaptive Gaussian Hermite (AGH) and c) the gold standard for multivariate integration Markov Chain Monte Carlo (MCMC)., Results: Random effects estimates generated by the LA were within 10% of the values obtained by the iGLMs, AGH and MCMC techniques. The H-lik approach was 4-30 times faster than AGH and nearly 800 times faster than MCMC. The major clinical inferences in this problem are the establishment of the non-linear relationship between the potassium level and the risk of mortality, as well as estimates of the individual and health care facility sources of variations for mortality risk in CRWD., Conclusions: We found that the direct implementation of the h-lik offers a computationally efficient, numerically accurate approach for the analysis of extremely large, real world repeated measures data via the h-lik approach to GLMMs. The clinical inference from our analysis may guide choices of treatment thresholds for treating potassium disorders in the clinic., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
49. Initial Outcomes Following Introduction of Percutaneous Arteriovenous Fistula Program with Comparison to Historical Surgically Created Fistulas.
- Author
-
Osofsky R, Byrd D, Reagor J, Das Gupta J, Clark R, Argyropoulos C, Fabre A, Owen J, Marek J, Rana MA, Langsfeld M, and Chavez L
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, New Mexico, Operative Time, Postoperative Complications etiology, Program Evaluation, Retrospective Studies, Time Factors, Treatment Outcome, Vascular Patency, Arteriovenous Shunt, Surgical adverse effects, Arteriovenous Shunt, Surgical instrumentation, Brachial Artery surgery, Endovascular Procedures adverse effects, Endovascular Procedures instrumentation, Renal Dialysis, Upper Extremity blood supply
- Abstract
Background: Recently, there has been an abundance of encouraging data regarding the creation of percutaneous arteriovenous fistulas. Despite promising data regarding their clinical maturation, a paucity of data exists which provides direct comparison between percutaneously created AVFs (pAVF) and open surgically created AVFs (sAVF). This study has 2 primary objectives: First, to compare clinical outcomes of pAVFs to sAVFs, with emphasis on clinical maturation and frequency of postoperative interventions to facilitate maturation. Second, to contribute toward the evidence-based incorporation of the pAVF procedure into the hemodialysis access algorithm., Methods: A single-center retrospective review was performed on all consecutive patients undergoing surgically created brachiocephalic arteriovenous fistula (BC-AVF, sAVF group) from January 1, 2018 to December 31, 2018 and Ellipsys-created percutaneous arteriovenous fistula (pAVF group) from January 1, 2019 to December 31, 2019. Comparative analysis between groups was performed., Results: A total of 24 patients underwent Ellipsys-created pAVF with mean age of 56.7 ± 22.6 years (12 males [50%], 12 females [50%]) and 62 patients underwent surgically created BC-AVF with mean age of 62.5 ± 13.2 years (32 males [52%], 30 females [48%]). Both the pAVF and sAVF groups had comparable mean operating times (60 ± 40 vs. 56 ± 25 min, P = 0.67) and frequency of procedural technical success (23 [96%] vs. 62 [100%], P = 0.28), respectively. The pAVF group had a lower clinical maturation rate (12 [52%] vs. 54 [87%], P = 0.003) and a higher primary failure rate (9 [39%] vs. 6 [10%], P = 0.003) when compared to the sAVF group. The pAVF group had an increased overall rate of undergoing a postoperative intervention (18 [78%] vs. 13 [21%], P< 0.001), as well as an increased number of total postoperative interventions (1.1 ± 0.9 vs. 0.3 ± 0.6 interventions, P< 0.001) compared to the sAVF group. Percutaneous transluminal angioplasty of the juxta anastomotic segment was the most prevalent postoperative intervention performed in the pAVF group and occurred at a significantly increased frequency when compared to the sAVF group rate (13 [57%] vs. 5 [8%], P< 0.001)., Conclusions: In our single-center retrospective review, patients undergoing Ellipsys-created pAVF in the first year following introduction of percutaneous endovascular had inferior rates of clinical maturation and underwent more postoperative interventions when compared to historical patients undergoing surgically created BC-AVF. Outcome discrepancies compared to previously reported Ellipsys data demonstrate a need for further studies examining the practical translatability of the pAVF., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
50. Initial 6-month quality review of a percutaneous endovascular arteriovenous fistula program.
- Author
-
Sultan S, Langsfeld M, Chavez L, Fabre A, Osofsky R, Argyropoulos C, and Owen JG
- Subjects
- Humans, Renal Dialysis, Retrospective Studies, Treatment Outcome, Vascular Patency, Arteriovenous Fistula, Arteriovenous Shunt, Surgical adverse effects
- Abstract
Background: Percutaneous arteriovenous fistulas have recently proven successful alternatives to surgical arteriovenous fistulas with encouraging initial results. The Ellipsys Endovascular Arteriovenous Fistula System utilizing ultrasound and thermal energy has recently received approval for use in the United States. At the University of New Mexico, we developed an integrated service between Vascular Surgery, Interventional Radiology, and Interventional Nephrology for percutaneous arteriovenous fistulas utilizing Ellipsys ., Methods: We performed a retrospective chart review of the initial 6 months (January 1
st 2019 to July 1st 2019) of 18 percutaneous arteriovenous fistula placements to evaluate our initial technical success rate, the number of arteriovenous fistulas meeting maturation characteristics or use in dialysis, and to identify areas for quality improvement., Results: Initial technical success was achieved in 17 out of 18 arteriovenous fistulas (94.4%). Three patients did not report for any follow-up at the end of the initial 6 months. Of the remaining patients, 7 out of 15 were using their arteriovenous fistulas or meeting maturation characteristics at the end of the study (46.7%). Patient loss to follow-up/no-show (16.7%), patient not yet requiring hemodialysis (27.8%), and poor post-surgical maturation and/or need for additional maturation procedures (55.6%) were the predominate reasons for non-use. We identified improved coordination of care, early intervention, and outpatient dialysis center education as the primary areas of focus for quality improvement., Conclusion: Initial technical success rate of percutaneous arteriovenous fistulas placement was comparable to published studies. Early and aggressive secondary angiographic interventions of arteriovenous fistulas failing to meet cannulation requirements, improved coordination of post-operative care, and outpatient dialysis center education appear to be the primary targets for quality improvement.- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.